Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients.
Citation
Hu B, Lin X, Lee HC, Huang X, Tidwell RSS, Ahn KW, Hu Z-H, Jabbour E, Verstovsek S, Ravandi F, Garcia-Manero G, Kharfan-Dabaja MA, Hossain NM, Marks DI, Kamble RT, Inamoto Y, Kindwall-Keller T, Saad A, Litzow MR, Savani BN, Hale GA, Bacher U, Gerds AT, Liesveld JL, Ustun C, Olsson RF, Daly A, Grunwald MR, Solh M, DeFilipp Z, Aljurf M, Wirk B, Akpek G, Nishihori T, Cerny J, Seo S, Hsu JW, Champlin R, de Lima M, Alyea E, Popat U, Sobecks R, Scott BL, Kantarjian H, Cortes J, Saber W.
Leukemia & Lymphoma. 2020, Dec 01: 61(12): 61(12):2811-2820. doi: 10.1080/10428194.2020.1783444. Epub 2020, Jul 14. PMCID:PMC8424781.
PubMed
PMID: 32662346
Abstract